Axonal channelopathies: An evolving concept in the pathogenesis of peripheral nerve disorders

Neurology

Volumn 47, Issue 1, 1996, Pages 18-21

  Gutmann, Ludwig ^a   Gutmann, Laurie ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOPYRIDINE; CIGUATOXIN; GANGLIOSIDE GM1; ION CHANNEL; LIDOCAINE; PHENYTOIN; POTASSIUM; POTASSIUM CHANNEL; SAXITOXIN; SODIUM; SODIUM CHANNEL; TETRODOTOXIN;

ACTION POTENTIAL; DEMYELINATION; ELECTROPHYSIOLOGY; HYPOCALCEMIA; MUSCLE WEAKNESS; MYOKYMIA; NERVE CONDUCTION; NERVE EXCITABILITY; NERVE FIBER DEGENERATION; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; PRIORITY JOURNAL; REVIEW;

EID: 0030054376     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.47.1.18     Document Type: Review

References (32)

1. Auger RG, Daube JR, Gomez MR, Lambert EH. Hereditary form of sustained muscle activity of peripheral nerve origin causing generalized myokymia and muscle stiffness. Ann Neurol 1984;15:13-21.
2. Jamieson PW, Katirji MB. Idiopathic generalized myokymia. Muscle Nerve 1994;17:42-51.
3. Oda K, Fukushima N, Shibasaki H, Ohnishi A. Hypoxia-sensitive hyperexcitability of the intramuscular nerve axons in Isaacs' syndrome. Ann Neurol 1989;25:140-145.
4. + channel blocking factor in the cerebrospinal fluid. Pflugers Arch 1992;421:552-557.
5. + currents in isolated rat myelinated nerve fibers. Ann Neurol 1995;37:436-442.
6. Waxman SG. Sodium channel blockage by antibodies: a new mechanism of neurological disease? Ann Neurol 1995;37:421-422.
7. Ptacek LJ, Johnson KJ, Griggs RC. Genetics and physiology of the myotonic muscle disorders. N Engl J Med 1993;328:482-489.
8. Honmou O, Utzschneider DA, Rizzo MA, et al. Delayed depolarization and slow sodium currents in cutaneous afferents. J Neurophysiol 1994;71:1627-1637.
9. Oda K, Araki K, Totoki T, Shibasaki H. Nerve conduction study of human tetrodotoxication. Neurology 1989;39:743-745.
10. Hille B. Ionic channels of excitable membranes. 2d ed. Sunderland, MA: Sinauer Associates, 1992.
11. Long RR, Sargent JC, Hammer K. Paralytic shellfish poisoning: a case report and serial electrophysiologic observations. Neurology 1990;40:1310-1312.
12. Cameron J, Flowers AE, Capra MF. Effects of ciguatoxin on nerve excitability in rats (Part I). J Neurol Sci 1991;101:87-92.
13. Scheuer PJ, Takahashi W, Tsutsumi J, Yoshida T. Ciguatoxin: isolation and chemical nature. Science 1967;155:1267-1268.
14. DiNubile MJ, Hokama Y. The ciguatera poisoning syndrome from farm-raised salmon. Ann Intern Med 1995;122:113-114.
15. Center for Disease Control. Ciguatoxin poisoning in Vermont. MMWR 1986;35:263-264.
16. DeFusco DJ, O'Dowd P, Hokama Y, Ott BR. Coma due to ciguatera poisoning in Rhode Island. Am J Med 1993;95:240-243.
17. + channel. FEBS Lett 1987;219:355-359.
18. Yokota T, Saito Y, Miyatake T. Conduction slowing without conduction block of compound muscle and nerve action potentials due to sodium channel block. J Neurol Sci 1994;124:220-224.
19. Berkit-Smith E, Krogh E. Motor nerve conduction velocity during dephenylhydantoin intoxication. Acta Neurol Scand 1971;47:265-271.
20. Marcus DJ, Swift TR, McDonald TF. Acute effect of phenytoin on peripheral nerve function in the rat. Muscle Nerve 1981;4: 48-50.
21. Brinkmeier H, Wollinsky KH, Seewald MJ, et al. Factors in the cerebrospinal fluid of multiple sclerosis patients interfering with voltage-dependent sodium channels. Neurosci Lett 1993;156:172-175.
22. Wurz A, Brinkmeier H, Wollinsky KH, Mehrkens HH, Kornhuber HH, Rudel R. Cerebrospinal fluid and serum from patients with inflammatory polyradiculoneuropathy have opposite effects on sodium channels. Muscle Nerve 1995;18:772-781.
23. Gutmann L. Limb and facial myokymia. Muscle Nerve 1991; 14:1043-1049.
24. Newsom-Davis J, Mills KR. Immunological associations of acquired neuromyotonia (Isaacs' syndrome). Brain 1993;116: 453-469.
25. + channels of peripheral nerves. Ann Neurol 1995;38:714-722.
26. Browne DL, Gancher ST, Nutt JG, et al. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat Genet 1994;8: 136-140.
27. Litt M, Kramer P, Browne D, et al. A gene for episodic ataxia/myokymia maps to chromosome 12p13. Am J Hum Genet 1994;55:702-709.
28. Brunt ERP, vanWeerden TW. Familial paroxysmal kinesiogenic ataxia and continuous myokymia. Brain 1990;113:1361-1382.
29. Griggs RC, Nutt JG. Autosomal dominant episodic ataxias. Ann Neurol 1995;37:285-287.
30. Brick JF, Gutmann L, Brick J, Apelgren KN, Riggs JE. Timber rattlesnake venom-induced myokymia: evidence for peripheral nerve origin. Neurology 1987;37:1545-1546.
31. Valdes JJ, Thompson RG, Wolff VL. Inhibition of calcium channel dihydropyridine receptor binding by purified Mojave toxin. Neurotoxicol Teratol 1989;11:129-133.
32. Kocsis JD, Bowe CM, Waxman SG. Different effects of 4-aminopyridine on sensory and motor fibers: pathogenesis of parathesias. Neurology 1986;36:117-120.